Complications of implantable venous ports
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) The patient's age is between 18 and 80 years old. (2) The patient has been diagnosed with a malignant tumor and has undergone the implantation of an infusion port. (3) The patient is in a convalescence period and will no longer use the infusion port for chemotherapy within one year. (4) The patient is expected to survive for more than half a year. (5) The implanted infusion port is a single-chamber port on the chest wall. (6) The patient has signed the informed consent form for participating in the clinical trial and is willing to be followed up.
Exclusion criteria
Exclusion criteria: (1) Patients with hematological malignancies (leukemia, lymphoma, multiple myeloma); (2) Patients with chronic kidney diseases (nephrotic syndrome, diabetic kidney disease, lupus nephritis); (3) BMI = 28 kg/m²; (4) Had a history of arterial-venous thrombosis within 1 year; (5) Had complications of infusion port: infection, intravenous thrombosis, catheter blockage, catheter tip displacement, catheter rupture or injury, drug extravasation. ; (6) There are patients with chronic cough and vomiting; (7) There are cases where the patients have cognitive dysfunction or mental disorders and are unable to understand the research process.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| infection;Catheter blockage;Inverted infusion port injection seat;thrombus;Displacement of catheter tip;Catheter rupture or breakage;Medication extravasation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Medical expenses;Patient satisfaction; | — |
Countries
China
Contacts
First Affiliated Hospital of Naval Medical University, Nursing Department